BLTE
Belite Bio
BLTE
BLTE
22 hedge funds and large institutions have $17.8M invested in Belite Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.67% more ownership
Funds ownership: 0.26% → 0.92% (+0.67%)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$10.6M | |
| 2 | +$762K | |
| 3 | +$628K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$522K |
| 5 |
Goldman Sachs
New York
|
+$399K |
Top Sellers
| 1 | -$225K | |
| 2 | -$165K | |
| 3 | -$94.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$78.8K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$45.5K |